Shanghai Heartcare Proposes Issuance of Domestic Shares to Boost Competitiveness
I'm PortAI, I can summarize articles.
Shanghai Heartcare Medical Technology Corp. Ltd. has proposed issuing 1,000,000 domestic shares at HK$45.00 each to enhance competitiveness and secure additional funds. The issuance is subject to shareholder approval and regulatory conditions. A special resolution will be proposed at upcoming meetings to authorize the board to manage the issuance process. The most recent analyst rating on the stock is a Hold with a HK$47.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments